20
Watson Pharma Private Limited Mumbai In, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Telmisartan, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R0-CEP 2010-261 - Rev 00
This Chemical Type CEP, issued on January 22, 2013, remains in force until December 13, 2013, ensuring its reliability within the pharmaceutical industry.
Substance Number 2154 associated with this CEP further emphasizes